The Role of Platelet-rich Plasma in Charcot Foot Reconstruction

Growing interest exists regarding the surgical correction of diabetes-associated Charcot foot arthropathy. These patients are complicated by morbid obesity, multiple medical comorbidities, severe osteoporosis, and impaired wound healing. Knowledge of the high complication rates for wound failure, wound infection, or mechanical failure has stimulated interest in the use of statically applied circular external fixation. This presentation deals with the potential role of pooled platelet-derived growth factors (platelet-rich concentrate) and pluripotential stem cells (bone marrow aspirate), combined with circular external fixation in the treatment of this complex patient population.

[1]  John D. Koerner,et al.  Correlation of growth factor levels at the fusion site of diabetic patients undergoing hindfoot arthrodesis and clinical outcome , 2011 .

[2]  M. Pinzur.  Use of Platelet-Rich Concentrate and Bone Marrow Aspirate in High-Risk Patients with Charcot Arthropathy of the Foot , 2009 .

[3]  M. Pinzur.  Use of platelet-rich concentrate and bone marrow aspirate in high-risk patients with Charcot arthropathy of the foot. , 2009, Foot & ankle international.

[4]  M. Tomlinson,et al.  Radiographic Measures as a Predictor of Ulcer Formation in Diabetic Charcot Midfoot , 2008, Foot & ankle international.

[5]  Frank A. Liporace,et al.  Complications of Ankle Fracture in Patients With Diabetes , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[6]  C. Laurencin,et al.  Fracture repair: challenges and opportunities. , 2008, The Journal of bone and joint surgery. American volume.

[7]  U. Albisinni,et al.  Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. , 2007, The Journal of bone and joint surgery. American volume.

[8]  M. Pinzur.  Neutral Ring Fixation for High-Risk Nonplantigrade Charcot Midfoot Deformity , 2007, Foot & ankle international.

[9]  John D. Koerner,et al.  Bioadjuvants for complex ankle and hindfoot reconstruction. , 2007, Foot and ankle clinics.

[10]  Frank A. Liporace,et al.  Diabetic fracture healing. , 2006, Foot and ankle clinics.

[11]  C. Saltzman,et al.  Reliability of AOFAS Diabetic Foot Questionnaire in Charcot Arthropathy: Stability, Internal Consistency, and Measurable Difference , 2005, Foot & ankle international.

[12]  C. Bono,et al.  Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. , 2005, Journal of surgical orthopaedic advances.

[13]  M. Pinzur.  Surgical Versus Accommodative Treatment for Charcot Arthropathy of the Midfoot , 2004, Foot & ankle international.

[14]  Sheldon S. Lin,et al.  Decreased Platelet Derived Growth Factor Expression During Fracture Healing in Diabetic Animals , 2003, Clinical orthopaedics and related research.

[15]  Sheldon S. Lin,et al.  The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[17]  REDUCTIONS IN GROWTH FACTORS IN THE FRACTURE HEMATOMA OF DIABETIC PATIENTS , 2002 .